minocycline hydrochloride
minocycline hydrochloride is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including minocycline hydrochloride, Minocin. Available dosage forms: tablet, extended release, injection.
Drug details
- Generic Name
- minocycline hydrochloride
- Brand Names
- minocycline hydrochloride, Minocin
- Application Number
- ANDA203553
- Sponsor
- Zydus Pharmaceuticals (USA) Inc.
- NDC Codes
- 17
- Dosage Forms
- TABLET, EXTENDED RELEASE, INJECTION
- Routes
- ORAL, INTRAVENOUS
- Active Ingredients
- MINOCYCLINE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS & USAGE Minocycline hydrochloride extended-release tablets is indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies ( 14 )]. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated [see Warnings and Precautions ( 5.12 )]. Minocycline hydrochloride extended-release tablets is a tetracycline-class drug indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. ( 1 ) Limitations of Use This formulation of minocycline has not been evaluated in the treatment of infections. To reduce the development of drug-resistant bacteria and to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated. ( 1 )